Trial Profile
Effect of ertugliflozin on the QTc interval in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jul 2018
Price :
$35
*
At a glance
- Drugs Ertugliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- 01 Jul 2018 Results published in the Clinical Pharmacology in Drug Development
- 22 Jul 2015 New trial record
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.